1. Grahame-Smith, D.G. Preclinical toxicological testing and safeguards in clinical trials. Eur. J. Clin. Pharmac., 1982, 22, 1–6
2. Safety requirements for the first use of new drugs and diagnostic agents in man. Published by the Council for International Organisation of Medical Sciences, Geneva, 1983
3. Czerwinski, A.W. The Phase 1 drug study. In Drug-induced Clinical Toxicity (ed. F.G McMahon), Futura, 1974, pp. 37–14
4. Goldberg, L.I., Besselaar, G.H., Arnold, J.D., Lamberger, L., Mitchell, J.R. and Whitsett, T.L. Phase I investigations. Clin. Pharmac. Ther., 1975, 18(5), 643–646
5. Idänpään-Heikkilä, J. A Review of Safety Information Obtained from Phase I, II and III Clinical Investigation of Sixteen Selected Drugs, U.S. Department of Health and Human Services, Public Health Service Food and Drug Administration, 1983